Characterization of solvents and optimization of stability and solubility of bioactive compounds used in lymphoma cell culture treatments

Ada Adilovic, Lejla Mahmutović, Emina Huseinbegović, Mirza Suljagic


Phytochemicals represent one of the rising agents in cancer research today. They are recognized as one the most abundant bio-active compounds found in many different sources, specifically in plants. Their anti-cancer effects have been frequently explored and reported in various research studies. However, the bioavailability and solubility of phytochemicals still represent the major issue in in vivo and in vitro research. This report analyses the effects of three different phytochemicals, commonly used for survival interference in malignant cancer clones, including thymoquinone (TQ), curcumin, and quercetin in a model of diffuse large B cell lymphoma (DLBCL). In order to characterize the impact of solubility of these compounds to their bioactivity in the DLBCL model, three different but highly widespread solvents were used. Determination of an optimal compound - solvent association is warranted when assessing the stability and activity of phytochemicals in cells. The results of this study indicate the dose-dependent decrease in cellular viability, including the treatments with all combinations of substances and solvents. In addition, we demonstrated that the choice of the solvent greatly influenced solubility and the overall effect of the compound in cancer cells.


Solvents, Bioactive compounds, Phytochemicals

Full Text:



R. Baishya, J. L. Hati Boruah, M. J. Bordoloi, D. Kumar, and P. Kalita, “Novel Drug Delivery System in Phytochemicals: Modern Era of Ancient Science,” in Herbal Medicine in India, S. Sen and R. Chakraborty, Eds. Singapore: Springer Singapore, 2020, pp. 175–189.

J. Krzyzanowska, A. Czubacka, and W. Oleszek, “Dietary Phytochemicals and Human Health,” in Bio-Farms for Nutraceuticals: Functional Food and Safety Control by Biosensors, M. T. Giardi, G. Rea, and B. Berra, Eds. Boston, MA: Springer US, 2010, pp. 74–98.

R. J. Molyneux, S. T. Lee, D. R. Gardner, K. E. Panter, and L. F. James, “Phytochemicals: the good, the bad and the ugly?,” Phytochemistry, vol. 68, no. 22–24, pp. 2973–2985, Dec. 2007, doi: 10.1016/j.phytochem.2007.09.004.

“Chemopreventive Effect of Curcumin, a Naturally Occurring Anti-Inflammatory Agent, during the Promotion/Progression Stages of Colon Cancer | Cancer Research.” (accessed Oct. 02, 2020).

K. T. Savjani, A. K. Gajjar, and J. K. Savjani, “Drug solubility: importance and enhancement techniques,” ISRN Pharm., vol. 2012, p. 195727, 2012, doi: 10.5402/2012/195727.

M. D’Archivio, C. Filesi, R. Varì, B. Scazzocchio, and R. Masella, “Bioavailability of the Polyphenols: Status and Controversies,” Int. J. Mol. Sci., vol. 11, no. 4, Art. no. 4, Apr. 2010, doi: 10.3390/ijms11041321.

I. Epriliati and I. R., “Bioavailability of Phytochemicals,” in Phytochemicals - A Global Perspective of Their Role in Nutrition and Health, V. Rao, Ed. InTech, 2012.

G. M. Cooper, “The Development and Causes of Cancer,” Cell Mol. Approach 2nd Ed., 2000, Accessed: Dec. 03, 2020. [Online]. Available:

H. F. Lodish, Ed., Molecular cell biology, 6th ed. New York: W.H. Freeman, 2008.

R. B. Mokhtariet al., “Combination therapy in combating cancer,” Oncotarget, vol. 8, no. 23, pp. 38022–38043, Mar. 2017, doi: 10.18632/oncotarget.16723.

K. B. Pandey and S. I. Rizvi, “Plant polyphenols as dietary antioxidants in human health and disease,” Oxid. Med. Cell. Longev., vol. 2, no. 5, pp. 270–278, 2009.

M. S. Atta, A. H. El-Far, F. A. Farrag, M. M. Abdel-Daim, S. K. Al Jaouni, and S. A. Mousa, “Thymoquinone Attenuates Cardiomyopathy in Streptozotocin-Treated Diabetic Rats,” Oxid. Med. Cell. Longev., vol. 2018, Oct. 2018, doi: 10.1155/2018/7845681.

A. Ahmad et al., “Solubility, solubility parameters and solution thermodynamics of thymoquinone in different mono solvents,” J. Mol. Liq., vol. 272, pp. 912–918, Dec. 2018, doi: 10.1016/j.molliq.2018.10.104.

M. A. Khan, “Thymoquinone, a constituent of prophetic medicine-black seed, is a miracle therapeutic molecule against multiple diseases,” Int. J. Health Sci., vol. 13, no. 1, pp. 1–2, 2019.

P. S. Koka, D. Mondal, M. Schultz, A. B. Abdel-Mageed, and K. C. Agrawal, “Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species,” Exp. Biol. Med. Maywood NJ, vol. 235, no. 6, pp. 751–760, Jun. 2010, doi: 10.1258/ebm.2010.009369.

S. Banerjee et al., “Review on Molecular and Therapeutic Potential of Thymoquinone in Cancer,” Nutr. Cancer, vol. 62, no. 7, p. 938, 2010, doi: 10.1080/01635581.2010.509832.

M. M. AbuKhader, “Thymoquinone in the clinical treatment of cancer: Fact or fiction?,” Pharmacogn. Rev., vol. 7, no. 14, pp. 117–120, 2013, doi: 10.4103/0973-7847.120509.

J. Pang et al., “Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells,” Oncotarget, vol. 8, no. 21, pp. 34453–34467, Mar. 2017, doi: 10.18632/oncotarget.16431.

B. A. Arslan, F. B. Isik, H. Gur, F. Ozen, and T. Catal, “Apoptotic Effect of Nigella sativa on Human Lymphoma U937 Cells,” Pharmacogn. Mag., vol. 13, no. Suppl 3, pp. S628–S632, Oct. 2017, doi: 10.4103/pm.pm_93_17.

I. F. F. Benzie and S. Wachtel-Galor, Eds., Herbal medicine: biomolecular and clinical aspects, 2nd ed. Boca Raton: CRC Press, 2011.

M. Tomeh, R. Hadianamrei, and X. Zhao, “A Review of Curcumin and Its Derivatives as Anticancer Agents,” Int. J. Mol. Sci., vol. 20, no. 5, p. 1033, Feb. 2019, doi: 10.3390/ijms20051033.

T. H. Kim et al., “Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity,” Int. J. Pharm., vol. 403, no. 1, pp. 285–291, Jan. 2011, doi: 10.1016/j.ijpharm.2010.10.041.

F. Liu et al., “Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway,” Oncol. Rep., vol. 39, no. 3, pp. 1523–1531, Mar. 2018, doi: 10.3892/or.2018.6188.

M. K. Shanmugamet al., “The Multifaceted Role of Curcumin in Cancer Prevention and Treatment,” Molecules, vol. 20, no. 2, Art. no. 2, Feb. 2015, doi: 10.3390/molecules20022728.

A. K. Panda, D. Chakraborty, I. Sarkar, T. Khan, and G. Sa, “New insights into therapeutic activity and anticancer properties of curcumin,” J. Exp. Pharmacol., vol. Volume 9, pp. 31–45, Mar. 2017, doi: 10.2147/JEP.S70568.

E. Cione, C. La Torre, R. Cannataro, M. C. Caroleo, P. Plastina, and L. Gallelli, “Quercetin, Epigallocatechin Gallate, Curcumin, and Resveratrol: From Dietary Sources to Human MicroRNA Modulation,” Mol. Basel Switz., vol. 25, no. 1, Dec. 2019, doi: 10.3390/molecules25010063.

J. K. Kim and S. U. Park, “Quercetin and its role in biological functions: an updated review,” EXCLI J. 17Doc856 ISSN 1611-2156, 2018, doi: 10.17179/EXCLI2018-1538.

M. Hashemzaeiet al., “Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo,” Oncol. Rep., vol. 38, no. 2, pp. 819–828, Aug. 2017, doi: 10.3892/or.2017.5766.

R. Shafabakhsh and Z. Asemi, “Quercetin: a natural compound for ovarian cancer treatment,” J. Ovarian Res., vol. 12, no. 1, p. 55, Dec. 2019, doi: 10.1186/s13048-019-0530-4.

B. N. Swanson, “Medical use of dimethyl sulfoxide (DMSO),” Rev. Clin. Basic Pharm., vol. 5, no. 1–2, pp. 1–33, Jun. 1985.

W. Qi, D. Ding, and R. J. Salvi*, “Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures,” Hear. Res., vol. 236, no. 1–2, pp. 52–60, Feb. 2008, doi: 10.1016/j.heares.2007.12.002.

K. Capriotti and J. A. Capriotti, “Dimethyl Sulfoxide,” J. Clin. Aesthetic Dermatol., vol. 5, no. 9, pp. 24–26, Sep. 2012.

M. Timm, L. Saaby, L. Moesby, and E. W. Hansen, “Considerations regarding use of solvents in in vitro cell based assays,” Cytotechnology, vol. 65, no. 5, pp. 887–894, Oct. 2013, doi: 10.1007/s10616-012-9530-6.

G. Da Violante, N. Zerrouk, I. Richard, G. Provot, J. C. Chaumeil, and P. Arnaud, “Evaluation of the cytotoxicity effect of dimethyl sulfoxide (DMSO) on Caco2/TC7 colon tumor cell cultures,” Biol. Pharm. Bull., vol. 25, no. 12, pp. 1600–1603, Dec. 2002, doi: 10.1248/bpb.25.1600.

A. A. Thorat and R. Suryanarayanan, “Characterization of Phosphate Buffered Saline (PBS) in Frozen State and after Freeze-Drying,” Pharm. Res., vol. 36, no. 7, p. 98, May 2019, doi: 10.1007/s11095-019-2619-2.

H. Zaatiti, J. Abdallah, Z. Nasr, G. Khazen, A. Sandler, and T. J. Abou-Antoun, “Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration,” Int. J. Oncol., vol. 52, no. 3, pp. 787–803, Jan. 2018, doi: 10.3892/ijo.2018.4236.

B. A. Kozikowskiet al., “The effect of room-temperature storage on the stability of compounds in DMSO,” J. Biomol. Screen., vol. 8, no. 2, pp. 205–209, Apr. 2003, doi: 10.1177/1087057103252617.

E. Huseinbegovic, D. Ler, and M. Suljagic, “Urine qRT-PCR assay as a screening tool for the detection of congenital human cytomegalovirus infection of infants,” vol. 8, no. 4, pp. 1951–1958, doi:

Tea Becirevic, M. Suljagic, and D. Ler, “Troubleshooting of RNA isolation methods in Papanicolaou HPV cervical smears,” vol. 8, no. 4, pp. 1959–1967, 2020.

P. Ferk and B. Dariš, “The influence of dimethyl sulfoxide (DMSO) on metabolic activity and morphology of melanoma cell line WM-266-4,” Cell. Mol. Biol. Noisy--Gd. Fr., vol. 64, no. 11, pp. 41–43, Aug. 2018.

B. Kollerup Madsen, M. Hilscher, D. Zetner, and J. Rosenberg, “Adverse reactions of dimethyl sulfoxide in humans: a systematic review,” F1000Research, vol. 7, p. 1746, 2018, doi: 10.12688/f1000research.16642.2.

S. Rajput, B. N. P. Kumar, K. K. Dey, I. Pal, A. Parekh, and M. Mandal, “Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells,” Life Sci., vol. 93, no. 21, pp. 783–790, Nov. 2013, doi: 10.1016/j.lfs.2013.09.009.

I. C. G. de Mendonçaet al., “Brazilian red propolis: phytochemical screening, antioxidant activity and effect against cancer cells,” BMC Complement. Altern. Med., vol. 15, no. 1, p. 357, Oct. 2015, doi: 10.1186/s12906-015-0888-9.

D. de M. Carvalho, K. P. Takeuchi, R. M. Geraldine, C. J. de Moura, and M. C. L. Torres, “Production, solubility and antioxidant activity of curcumin nanosuspension,” Food Sci. Technol., vol. 35, pp. 115–119, 2015.



  • There are currently no refbacks.

Copyright (c) 2020 Ada Adilovic, Lejla Mahmutović, Emina Huseinbegović, Mirza Suljagic

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN: 2303-4521

Digital Object Identifier DOI: 10.21533/pen

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License